enzastaurin has been researched along with Demyelinating Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, S; Bittner, S; Gaikwad, S; Grabitz, C; Iwantscheff, S; Lanz, TV; Litzenburger, UM; Meuth, SG; Mittelbronn, M; Opitz, CA; Osswald, M; Ott, M; Platten, M; Sahm, F; Schuhmann, MK; von Deimling, A; Wick, W; Wiestler, B; Winkler, F | 1 |
1 other study(ies) available for enzastaurin and Demyelinating Diseases
| Article | Year |
|---|---|
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Topics: Animals; Blood-Brain Barrier; Cell Proliferation; Claudin-3; Claudin-5; Cytokines; Demyelinating Diseases; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Female; Gene Expression Profiling; Immunohistochemistry; Indoles; Inflammation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microscopy, Confocal; Protein Kinase C beta; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Tight Junctions; Transendothelial and Transepithelial Migration; Zonula Occludens-1 Protein | 2013 |